Synthetic BiologyFrontiers in Bioengineering and BiotechnologyPeer-reviewed
Cell-free glycoengineering of the recombinant SARS-CoV-2 spike glycoprotein
Johannes Ruhnau, Valerian Grote, Mariana Juarez-Osorio…·Udo Reichl
The paper describes an in-vitro glycoengineering approach to modify N-glycans on recombinant SARS-CoV-2 spike glycoprotein to mimic mammalian cell-derived glycoforms.
10 citations